CIPDB › China Industry › Chemicals › Pharmaceutical Intermediate
Metaboact Slu-PP-332 99% Err Activator Fat-Burning Metabolic Booster Research1
Pharmaceutical IntermediateSlu-PP-332Peptide Slu-PP-332
Xi'an Ruitang Co., Ltd.
Preview:
Product Description MetaboAct SLU-PP-332 99% ERR Activator Fat-Burning Metabolic Booster Research Basic Information:Product NameSlu-PP-332 PowderNameSlu-PP-332MFC18H14N2O2MW290.32SLU-PP-332 (CAS 303760-60-3) is a full agonist of estrogen receptor related receptors with multiple pharmacological effects.SLU-PP-332 works by activating nuclear receptors ERRs, which are involved in regulating energy metabolism. After administration, it induced physiological adaptive changes similar to those observed during exercise, namely increased fatty acid oxidation and energy expenditure. Specifically, research has shown that SLU-PP-332 leads to: 1 Increased fatty acid oxidation: increased by 25% compared to the control group. 2. Reduce carbohydrate utilization: indicating a bias towards lipid metabolism. 3. Enhance glucose uptake, especially in muscle tissue after long-term treatment. SLU-PP-332 has potential applications in the following areas: 1 Metabolic syndrome treatment: by reducing fat mass and improving sensitivity. 2. Obesity management: The efficacy of weight loss and improved metabolic health was demonstrated in a mouse model. 3. Simulated exercise research: providing alternative solutions for people who are unable to engage in regular activities due to health restrictions. Application&Function:1. Activate ERRs nuclear receptorsIncreased fatty acid oxidation: compared to the control group, it increased by 25%.Reducing carbohydrate utilization: indicates a metabolic bias towards lipid metabolism.Enhance glucose uptake, especially in muscle tissue after long-term treatment.2. Improve metabolic healthMetabolic syndrome treatment: by reducing fat mass and improving sensitivity.Obesity management: demonstrated efficacy in reducing weight and improving metabolic health in a mouse model.Reducing liver triglycerides: Preclinical studies have shown that this drug effectively reduces liver triglyceride levels and no significant adverse reactions have been observed in animal models.3. Enhance muscle functionSLU-PP-332 can also enhance mitochondrial function and cellular respiration in skeletal muscle cell lines, increase IIa type oxidized skeletal muscle fibers, and enhance the exercise tolerance of skeletal muscle cell lines. This indicates its potential for improving muscle function and athletic performance.Hot Products List
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...